Study: U.S. experiences rapid growth in specialty drug spending
Specialty drugs more than doubled as a share of retail fills for the overall U.S. population between 2010 and 2017, according to a study using various sources and published in Health Affairs, growing from 1% to 2.3%.
Despite representing a small percentage of overall prescriptions, spending on these drugs accounted for approximately half of the country’s total spending on retail, mail-order and provider-administered drugs in 2018; however, the study noted that the cost of these drugs are difficult to track due to the use of manufacturer rebates.
Net spending was divided at 31.5% for all retail and mail-order drugs for Medicare Part D, 37.8% for Medicaid and 43.6% of private drug spending.
Related News Articles
Headline
The net prices of five drugs included in a new study from the Institute for Clinical and Economic Review increased without clinical justification in 2023.…
Headline
The AHA Dec. 9 said it supports a potential Medicare $2 Drug List Model, where people enrolled in a Part D plan would have access to certain prescription drugs…
Headline
The Centers for Medicare & Medicaid Services Oct. 9 released a request for information and a sample list of prescription drugs it intends to include under…
Headline
The Centers for Medicare & Medicaid Services Oct. 21 will host a webinar on meeting its new hospital price transparency requirements becoming effective Jan…
Headline
The Department of Health and Human Services Oct. 2 released final guidance detailing the process for the second cycle of negotiations under the Medicare Drug…
Headline
The Centers for Medicare & Medicaid Services Sept. 27 announced that average premiums, benefits and plan choices for Medicare Advantage and Part D will…